PT-141 research centers on bremelanotide, a synthetic cyclic heptapeptide melanocortin-receptor agonist that has become a valuable tool compound for investigators studying central nervous system (CNS) control of reproductive behavior. Unlike peripherally acting vasoactive agents, PT-141 is examined in preclinical models specifically because it appears to engage neural melanocortin circuitry — most notably the melanocortin-4 receptor (MC4R) — rather than the peripheral vasculature. This distinction makes it a focal point for laboratories investigating how the melanocortin system links hypothalamic signaling to motivational and reproductive-behavior outputs.
Research Use Only (RUO): PT-141 (bremelanotide) supplied by NeuroLabs is intended strictly for laboratory, in-vitro, and preclinical research. It is not for human or veterinary use, is not a drug in this context, and has not been evaluated by the FDA for the uses discussed here. Nothing in this guide is intended to diagnose, treat, cure, or prevent any disease, and no human dosing or administration guidance is provided.
What Is Bremelanotide (PT-141)?
Bremelanotide is a cyclic seven-amino-acid peptide derived from the alpha-melanocyte-stimulating hormone (α-MSH) lineage. It is the deaminated, biologically active metabolite of Melanotan II (MT-II), formed when the C-terminal amide of MT-II is cleaved to a carboxylic acid. That single structural difference substantially shifts the pharmacology studied in the literature: whereas MT-II retains strong MC1R activity associated with pigmentation research, PT-141 is investigated more for its central melanocortin activity and behavioral endpoints. Researchers comparing the two commonly consult our PT-141 vs Melanotan II melanocortin research overview for a structure-activity breakdown.
Key physicochemical properties for laboratory handling
| Property | Detail (research reference) |
|---|---|
| Class | Cyclic heptapeptide, melanocortin agonist |
| Origin | Active metabolite of Melanotan II (α-MSH analog) |
| Primary targets studied | MC4R and MC3R (with residual MC1R activity) |
| Molecular formula | C50H68N14O10 |
| Molar mass | ~1025 g/mol |
| Physical form | Lyophilized powder |
The MC4 Receptor: Why It Anchors PT-141 Research
The melanocortin system comprises five G-protein-coupled receptors (MC1R–MC5R), each coupled primarily to Gs and adenylyl cyclase, driving cyclic AMP (cAMP) accumulation upon agonist binding. Of these, MC4R is densely expressed in the hypothalamus, limbic structures, and brainstem — regions that integrate energy balance, arousal, and reproductive signaling. PT-141 is studied as a non-selective agonist with meaningful potency at MC4R and MC3R, and this central engagement is the mechanistic reason the peptide is used to interrogate CNS-mediated behavior rather than peripheral hemodynamics.
In receptor-pharmacology assays, researchers characterize PT-141 by measuring cAMP responses in cells expressing individual melanocortin subtypes, allowing quantification of potency (EC50) and relative selectivity across MC3R, MC4R, and MC1R. Because subtype selectivity dictates which downstream circuit is activated, selectivity profiling is central to interpreting any behavioral result. Investigators building selectivity panels often reference our melanocortin receptor selectivity in research guide and the broader melanocortin system receptor mechanism guide.
Proposed CNS signaling cascade under study
- Agonist binding: PT-141 binds MC4R on hypothalamic neurons (e.g., paraventricular nucleus, medial preoptic area in animal models).
- cAMP/PKA activation: Gs coupling elevates intracellular cAMP, activating protein kinase A.
- Downstream neuromodulation: Preclinical work associates MC4R activation with dopaminergic and oxytocinergic signaling in circuits linked to arousal and pair-related behavior.
- Behavioral readout: In rodent models these cascades are correlated with quantifiable reproductive-behavior endpoints.
Reproductive-Behavior Research Pathways
The most distinctive angle in the PT-141 literature is its apparent action on centrally mediated reproductive behavior. Classic preclinical studies in rodent models examined solicitation and proceptive behaviors after central melanocortin agonism, distinguishing these motivational endpoints from peripheral reflex measures. This is why PT-141 is frequently framed as a probe of "central" versus "peripheral" mechanisms in comparative pharmacology.
Because MC4R sits at the intersection of energy homeostasis and reproductive signaling, PT-141 is also studied alongside upstream reproductive-axis modulators. Laboratories mapping the hypothalamic-pituitary-gonadal axis often pair melanocortin tool compounds with kisspeptin-focused work; see our kisspeptin research guide on the reproductive axis for how these signaling nodes are studied together. This systems-level view connects back to the parent pillar on melanocortin and reproductive peptides.
Common experimental endpoints in the literature
- Receptor binding affinity and cAMP functional assays across MC subtypes.
- c-Fos immunohistochemistry to map neural activation patterns after central administration in animal models.
- Behavioral scoring of proceptive/solicitation behaviors in validated rodent paradigms.
- Comparative studies against MT-II to dissect selectivity-driven differences.
Laboratory Handling: Reconstitution & Storage
PT-141 is supplied as a lyophilized powder for research preparation. The following are general laboratory handling practices for peptide research materials — not administration instructions.
| Parameter | Laboratory practice |
|---|---|
| Reconstitution solvent | Sterile or bacteriostatic water; add slowly down the vial wall, do not agitate vigorously. |
| Lyophilized storage | Store desiccated at −20 °C; protect from light. |
| Reconstituted storage | Refrigerate at 2–8 °C; use within a short working window per lab SOP. |
| Freeze-thaw | Minimize cycles; aliquot to preserve peptide integrity. |
| Handling | Standard PPE; treat as a research chemical. |
Every lot of PT-141 10mg from NeuroLabs is ≥99% purity, third-party COA-tested, and ships same-day within the USA, so investigators can verify identity and purity against the accompanying certificate of analysis before beginning work.
Quality Considerations for Reproducible Data
Peptide purity directly affects reproducibility. Impurities, truncated sequences, or residual counter-ions can confound cAMP assays and shift apparent potency. For that reason, researchers should confirm the analytical COA (HPLC purity and mass-spec identity) matches the stated ≥99% specification, and should record lot numbers alongside experimental data. Consistent sourcing reduces inter-experiment variability when PT-141 is used as a reference melanocortin agonist across studies.
Summary
PT-141 (bremelanotide) is a central melanocortin agonist whose value in the laboratory lies in its MC4R/MC3R engagement and its ability to probe CNS-mediated reproductive-behavior pathways distinct from peripheral mechanisms. Its origin as the active metabolite of Melanotan II, its Gs/cAMP signaling, and its well-characterized behavioral endpoints make it a robust tool compound for melanocortin and reproductive-axis research — always within a strictly research-use-only framework.